KPKrantarat Peeyananjarassri

Krantarat Peeyananjarassri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Krantarat Peeyananjarassri has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Satit Klangsin

    Department of Obstetrics and Gynecology, Faculty of Medicine Prince of Songkla University Songkhla Thailand

    5 shared publications
  • Saranya Wattanakumtornkul

    Department of Obstetrics and Gynecology, Faculty of Medicine Prince of Songkla University Songkhla Thailand

    4 shared publications
  • Tippawan Liabsuetrakul

    Prince of Songkla University

    4 shared publications
  • Kriengsak Dhanaworavibul

    Department of Obstetrics and Gynecology Faculty of Medicine, Prince of Songkla University Songkhla Thailand

    3 shared publications
  • Chainarong Choksuchat

    Department of Obstetrics and Gynecology Faculty of Medicine, Prince of Songkla University Songkhla Thailand

    2 shared publications
  • Chatpavit Getpook

    Department of Obstetrics and Gynecology Faculty of Medicine, Prince of Songkla University Songkhla Thailand

    2 shared publications

Latest Publications

  • Effects of Estriol‐Lactobacilli Combination Versus Polycarbophil‐Based Vaginal Moisturizer on Post‐Radiation Vaginitis in Women With Cervical Cancer: A Randomized Controlled Trial

    by Natcha Koohachaiskun, Thiti Atjimakul, Krantarat Peeyananjarassri, Satit Klangsin, Kanet Kanjanapradit

    Objective: To compare the efficacy of an estriol‐lactobacilli combination vaginal tablet (E3/L) and polycarbophil‐based vaginal moisturizer (PBVM) in women with post‐radiation vaginitis following cervical cancer treatment. Methods: This open‐label, randomized controlled trial recruited 34 women with Stages I–III cervical cancer who had completed pelvic radiotherapy and developed vaginal toxicity symptoms. Participants were randomized 1:1 to E3/L (Gynoflor) or PBVM (Regelle) for 4 weeks. The primary outcome was change in vaginal maturation value (VMV). Secondary outcomes included changes in vaginal pH, vaginal toxicity symptom scores, and Female Sexual Function Index (FSFI) scores. Results: The median improvement in VMV was significantly greater with E3/L than with PBVM (19.65 [IQR: 0–39.5] vs. 2.08 [IQR: 0–20.1] points; p = 0.035; 95% CI: 10.22–32.59). Vaginal dryness and inflammation improved significantly in the E3/L group. Changes in vaginal pH, dyspareunia, and vaginal pain were similar between groups. Although the FSFI change was greater with E3/L (median +6 vs. +2; p = 0.01), absolute FSFI scores at Week 4 were similar, and clinical significance is uncertain. Both treatments were well tolerated. Conclusion: In women with cervical cancer and radiation‐induced vaginitis, E3/L showed greater short‐term improvements in vaginal epithelial maturation, dryness, and inflammation than PBVM over 4 weeks. These findings are exploratory given the modest sample size, open‐label design, and short follow‐up; larger double‐blind randomized trials with extended follow‐up are needed to confirm these results. Trial Registration: Thai Clinical Trials Registry: TCTR2024051001

  • Effects of estetrol/drospirenone versus ethinyl estradiol/drospirenone on glucose tolerance in women with polycystic ovary syndrome: A randomised controlled trial

    by Phattarika Bunyapipat, Satit Klangsin, Krantarat Peeyananjarassri, Saranya Wattanakumtornkul, Sirapat Katesuwan, Alan Geater, Amornkan Numit

    Aims: To compare the effects of estetrol/drospirenone ( E4 / DRSP ) and ethinyl estradiol/drospirenone ( EE / DRSP ) on glucose tolerance in women with polycystic ovary syndrome ( PCOS ). Materials and Methods: This open‐label, randomised crossover trial was conducted from January 2024 to January 2025. Women with PCOS , diagnosed according to the modified 2003 Rotterdam criteria, received three cycles of either E4 15 mg/ DRSP 3 mg or EE 30 mcg/ DRSP 3 mg. After a 2‐month washout, participants crossed over to the alternate regimen for three further cycles. Glucose tolerance (via 75 g oral glucose tolerance test [ OGTT ]), insulin levels and homeostatic model assessment for insulin resistance ( HOMA ‐ IR ) were compared between treatments. Results: Of 66 women enrolled, 61 completed both treatment phases. Baseline characteristics were comparable. No significant differences were observed in the mean changes in 2‐h OGTT ( E4 / DRSP : 4.65 mg/ dL [95% confidence interval ( CI ) −2.37 to 11.66] vs. EE / DRSP : 14.40 mg/ dL [95% CI 7.50–21.29]; p = 0.05; upper boundary for non‐inferiority margin of 14.29), 1‐h insulin levels (−1.04 μU / mL [95% CI −25.94 to 23.86] vs. −0.77 μU / mL [95% CI −25.24 to 23.70]; p = 0.99; upper boundary for non‐inferiority margin of 50.72) or HOMA ‐ IR (0.28 [95% CI −0.24 to 0.80] vs. 0.60 [95% CI 0.09–1.11]; p = 0.39; upper boundary for non‐inferiority margin of 1.06). Conclusion: E4/DRSP was not inferior to EE/DRSP in its effects on glucose tolerance, insulin levels and HOMA‐IR, supporting its use as a potential oral contraceptive option in women with PCOS.


  • Etiologies and clinical characteristics of primary amenorrhea: A study from a quaternary care hospital in southern Thailand

    by Krantarat Peeyananjarassri, Satit Klangsin, Patchayapan Bhumsiriwilai, Saranya Wattanakumtornkul, Rassamee Chotipanvithayakul

    Aim: This study aimed to investigate the causes and clinical characteristics of patients presenting with primary amenorrhea. Methods: A retrospective review was conducted on patients diagnosed with primary amenorrhea at a quaternary care center in southern Thailand between January 2002 and September 2024. Patients with missing data or ambiguous genitalia were excluded. Primary amenorrhea was categorized into three main etiologies: hypergonadotropic hypogonadism (characterized by low serum estradiol and elevated follicle‐stimulating hormone [FSH] levels, indicative of ovarian or gonadal disorders), hypogonadotropic hypogonadism (low serum estradiol with low or normal serum FSH levels, associated with hypothalamic–pituitary dysfunction), and eugonadotropic eugonadism (disorders of the uterus or genital outflow tract). Other conditions included anovulation, hyperprolactinemia, and thyroid disorders. Results: Of the 320 patients included, 150 (46.9%) were classified as having eugonadotropic eugonadism. Among these, Müllerian agenesis was the most common cause (33.8%), followed by gonadal dysgenesis (28.8%). Patients with genital outflow tract obstruction were diagnosed at a significantly younger median age compared to those with Müllerian agenesis (14 years [interquartile range; IQR 13, 16] vs. 20 years [IQR 18, 24]; p < 0.001). Serum FSH levels differed significantly across the three main categories, with higher levels observed in hypergonadotropic hypogonadism (81.1 IU/L [IQR 65.2, 95.0]) compared to hypogonadotropic hypogonadism (0.8 IU/L [IQR 0.3, 3.4]) and eugonadotropic eugonadism (5.2 IU/L [IQR 3.5, 6.3], p < 0.001). Among patients with hypergonadotropic hypogonadism and hypogonadotropic hypogonadism who underwent ultrasonography (USG) ( n = 100), the uterus was not visualized in 44 cases. Conclusion: Müllerian agenesis emerged as the most frequent cause of primary amenorrhea, although it tended to be diagnosed later than genital outflow tract obstruction. Caution is warranted when assessing the presence of the uterus by USG, particularly in patients with hypergonadotropic hypogonadism or hypogonadotropic hypogonadism.


  • Causes and clinical characteristics of women with primary amenorrhea and ovarian or gonadal disorders at a quaternary hospital

    by Krantarat Peeyananjarassri, Satit Klangsin, Apisada Chumkam, Saranya Wattanakumtornkul, Kriengsak Dhanaworavibul, Chainarong Choksuchat, Chatpavit Getpook, Phawat Matemanosak, Chariyawan Charalsawadi, Worathai Maisrikhaww

    Aim: To evaluate the causes and clinical characteristics of primary amenorrhea and ovarian or gonadal disorders in women.Methods: The medical records of all women evaluated for primary amenorrhea between January 2002 and December 2023 were retrospectively reviewed. Women with missing data were excluded from the study. Disorders of the ovary or gonads (hypergonadotropic hypogonadism) were defined as increased serum follicle‐stimulating hormone (FSH) levels (>40 mIU/mL).Results: Over a 21‐year period, after excluding 1 woman with incomplete data, the study included 87 women who met the inclusion criteria. The median age at presentation was 18 years (interquartile range [IQR], 17–20). The median estradiol level was 5 pg/mL (IQR 5–10.4), and the median FSH level was 80 mIU/mL (IQR 63.1–94.9). The most common cause of primary amenorrhea was Turner syndrome (TS), followed by 46,XX and 46,XY gonadal dysgenesis. The median height was 147 cm (IQR, 140–158.7), and 50 women (57.5%) had karyotypic abnormalities, with TS being the most common abnormality.Conclusion: TS was identified as the most common cause of primary amenorrhea with ovarian or gonadal disorders.

  • Open Access

    Clinical features and management of women with Mayer-Rokitansky-Küster-Hauser syndrome in a Thai population

    by Phawat Matemanosak, Krantarat Peeyananjarassri, Satit Klangsin, Saranya Wattanakumtornkul, Kriengsak Dhanaworavibul, Chainarong Choksuchat, Chatpavit Getpook

    Objective This study aimed to describe the clinical features, associated extragenital anomalies, and management of Mayer- Rokitansky-Küster-Hauser (MRKH) syndrome in a Thai population.Methods This retrospective study analyzed the medical records of 96 patients with MRKH syndrome diagnosed and treated at a university hospital and tertiary referral center in southern Thailand between 2000 and 2022.Results The study included 96 patients with MRKH syndrome. The most common symptom was primary amenorrhea (88.5%), followed by difficulty or inability to engage in sexual intercourse (9.4%) and pelvic mass (2.1%). Notably, 80.3% of the patients did not have extragenital malformations and were diagnosed with MRKH type I (typical form), whereas 19.7% were categorized as MRKH type II (atypical form). Skeletal malformations were the most frequent extragenital anomalies and were present in 19.5% of patients, with scoliosis being the most common skeletal condition. Other extragenital malformations included renal (8.5%) and neurological (1.0%) abnormalities. Clinical vaginal examination revealed complete atresia in 21.8% and vaginal hypoplasia (median vaginal length, 3 cm) in 78.2% of the patients. Half of the patients did not receive treatment because they had not engaged in sexual intercourse. In this cohort, 41.7% of the patients had no difficulty performing sexual intercourse. Hence, self-dilation therapy or concomitant dilation was recommended. Only eight patients (8.3%) underwent surgical reconstruction of the vagina.Conclusion This study confirmed the complexity and heterogeneity of the phenotypic manifestations of MRKH, including the degree of vaginal atresia and types and rates of associated malformations.


  • Open Access

    Ovarian steroid cell tumor (not otherwise specified) with subsequent spontaneous pregnancy after tumor removal: a case report and literature review

    by Phawat Matemanosak, Krantarat Peeyananjarassri, Chitkasaem Suwanrath, Saranya Wattanakumtornkul, Satit Klangsin, Ekasak Thiangphak, Kanet Kanjanapradit

    Steroid cell tumors not otherwise specified are rare sex cord-stromal tumors of the ovary that may produce various steroids and are associated with hirsutism and virilization. We report a rare case of ovarian steroid cell tumor with subsequent spontaneous pregnancy after tumor removal. A 31-year-old woman presented with secondary amenorrhea, hirsutism, and inability to conceive. Clinical and diagnostic evaluations revealed a left adnexal mass and elevated serum total testosterone and 17α-hydroxyprogesterone levels. She underwent a left salpingo-oophorectomy, and histopathological examination confirmed the diagnosis of a steroid cell tumor not otherwise specified. Her serum total testosterone and 17α-hydroxyprogesterone normalized one month after surgery. Her menses resumed spontaneously one month after the operation. She spontaneously conceived 12 months after the surgery. The patient had an uncomplicated pregnancy and delivered a healthy male infant. In addition, we reviewed the literature on steroid cell tumors not otherwise specified with subsequent spontaneous pregnancies after surgery and data regarding pregnancy outcomes.


  • Impact of appendectomy of a grossly normal appendix on the survival outcomes of mucinous ovarian carcinomas in a tertiary hospital

    by Krantarat Peeyananjarassri, Kulisara Nanthamongkolkul, Ingporn Jiamset, Wuttipong Chusook, Sathana Boonyapipat, Rakchai Buhachat

    Objective: To evaluate the survival outcomes of appendectomy for a grossly normal appendix in patients with mucinous ovarian carcinomas.Methods: Retrospective cohort study. Patients with mucinous ovarian carcinomas with grossly normal appendices who underwent primary surgery between 2002 and 2022 were enrolled. The overall survival (OS) and progression‐free survival (PFS) of appendectomy and non‐appendectomy groups were analyzed using the Kaplan–Meier method and compared using the log‐rank test. Univariate and multivariate Cox regression analyses were used to determine the independent factors associated with OS and PFS.Results: Of 192 patients, appendectomy was performed in 138 (71.9%). Three (1.6%) patients had primary appendiceal tumors and two (1.0%) had appendiceal metastases of ovarian origin. The median follow‐up time was 68.8 months. The OS and PFS were better in patients in the appendectomy group than in those in the non‐appendectomy group (5‐year OS: 80.72% vs. 65.05%, P = 0.012; 5‐year PFS: 76.32% vs. 58.60%, P = 0.020). Independent factors associated with poor OS and PFS were no omentectomy, peritoneal seeding, and advanced International Federation of Gynecology and Obstetrics (FIGO) stage.Conclusion: Appendectomy of a grossly normal appendix was not an independent prognostic factor for OS and PFS in patients with mucinous ovarian carcinomas.


  • Open Access

    Appendiceal tumors in patients undergoing primary surgery for mucinous ovarian tumors in a tertiary hospital, in Southern Thailand

    by Kulisara Nanthamongkolkul, Panote Wattanapaisal, Sathana Boonyapipat, Yuthasak Suphasynth, Aroontorn Pichatechaiyoot, Alan Frederick Geater, Kanita Kayasut, Krantarat Peeyananjarassri


  • Open Access

    The impact of appendectomy in grossly normal appendix on the survival outcomes among mucinous borderline ovarian tumors and mucinous ovarian carcinomas, in a tertiary hospital

    by Kulisara Nanthamongkolkul, Krantarat Peeyananjarassri, Ingporn Jiamset, Wuttipong Chusook, Sathana Boonyapipat, Rakchai Buhachat